Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117105845A reveals a stable electrophilic trifluoromethylselenide reagent enabling high-yield isoxazole synthesis for pharmaceutical intermediates with improved supply chain reliability.
Patent CN112209947A discloses a mild, high-yield organocatalytic route to chiral indoxazinones with potent anticancer activity, offering significant cost reduction in API manufacturing.
Patent CN113735826B details Pd-catalyzed carbonylation for quinolones. Offers scalable routes and cost reduction in pharma manufacturing with high purity.
Novel Pd-catalyzed carbonylation patent CN115286628B offers high purity intermediates with scalable supply chain advantages for global pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation method offers high yields and substrate tolerance for scalable drug molecule production.
Novel metal-free catalytic route for 1,3-dihydroisobenzofuran derivatives offering high yields and mild conditions for pharma intermediates.
Novel NTFTS reagent enables efficient trifluoroacetophenone synthesis. Reduces waste, improves yield for pharmaceutical intermediates manufacturing.
Novel FeCl3-catalyzed route offers high yields and scalability for quinazolinone derivatives, reducing costs in API manufacturing.
Novel deep eutectic solvent method for stilbene compounds reduces environmental impact and operational costs significantly. Ideal for pharmaceutical intermediate supply chains seeking reliable green chemistry solutions.
Patent CN110156658A reveals efficient chiral phosphoric acid catalysis for triarylmethane derivatives ensuring high purity and scalable supply chain solutions.
Patent CN113307778A reveals a mild Mo/Cu-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102718711A reveals a novel route for (R)-alpha-amino caprolactam hydrochloride. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity pharmaceutical intermediates with scalable cost reduction.
Patent CN115353511A reveals a safe Pd-catalyzed carbonylation method for synthesizing indolinone-imidazole hybrids, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for API production.
Patent CN109180406B details a Pd-catalyzed one-pot synthesis offering high stereoselectivity and mild conditions for efficient pharmaceutical intermediate manufacturing.
Patent CN111423381A reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method using benzyl formate. High yield, broad substrate scope, no external oxidant required for efficient pharmaceutical intermediate production.
Patent CN103772279B details Pd-catalyzed synthesis of 4-bromoisoquinolinone. Offers high purity, simplified purification, and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN113735778B reveals efficient silver oxide promoted synthesis. Enables cost reduction in pharmaceutical manufacturing with high purity.